Organization
Institute of Biomedicine of Seville (IBiS)
2 abstracts
Abstract
Unveiling the relationship between the UGT2B gene family and neoadjuvant treatment response in patients with HER2-positive breast cancer.Org: Instituto Biomedicina Sevilla, Institute of Biomedicine of Seville (IBiS), Andalusian - Roche Network Mixed Alliance in Precision Medical Oncology,
Abstract
HER2-low expression as a prognostic factor in patients treated with CDK4/6 inhibitors: A retrospective analysis.Org: Virgen del Rocio Hospital, Institute of Biomedicine of Seville (IBiS), CSIC, Universidad de Sevilla, Andalusian - Roche Network Mixed Alliance in Precision Medical Oncology,